Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL   SUMMER 2007 , Volume 6 , Number 2 (53); Page(s) 199 To 209.
 
Paper: 

ABNORMAL GLUCOSE TOLERANCE AND DIABETES MELLITUS IN BETA THALASSEMIC PATIENTS WITH TRANSFUSION DEPENDENT AT AHWAZ THALASSEMIA RESEARCH CENTER

 
 
Author(s):  COMPANI F.*, ZANDIAN KH.M., PEDRAM M., SHAHBAZIAN H., REZAEI N.
 
* AHWAZ THALASSEMIA AND HEMOGLUBINOPATHIES RESEARCH CENTER, AHWAZ UNIVERSITY OF MEDICAL SCIENCES, AHWAZ
 
Abstract: 

Objective: Impaired glucose tolerance (IGT) and diabetes mellitus (DM) is a frequent complication in patient with b thalassemia. It is believed to be a consequence of damage inflicted by iron overload. The aim of this study was to evaluate the prevalence of diabetes mellitus and glucose intolerance and its relation to predisposing factors.

Subjects and Methods: A total of 195 transfusion dependent b thalassemia patients> 5 years of age referring to Ahwaz Thalassemia Research Center were prospectively interviewed. For diagnosis of DM and IGT the ADA and WHO criteria was used.

Results: The prevalence of impaired glucose tolerance was 19% (37 of 195) and that of diabetes was 16/4% (32 of 195).37 patients (19%) had positive family history of diabetes. In patient with serum ferritin above or under 2000 mg/l diabetes or impaired glucose tolerance were found in 49% and 20.8%. We found that in patients with large liver and spleen size prone to glucoseintolerance.

Conclusion: The finding from this study showed that early and regular use of deferoxamine in b thalassemia patients with serum ferritin level above 2000 mg/l, liver and spleen enlargement and positive family history of diabetes, reduces the body iron burden and can help protect against diabetes mellitus.

 
Keyword(s): IMPAIRED GLUCOSE TOLERANCE, DIABETES MELLITUS, BETA THALASSEMIA, FERRITIN, DESFERRAL
 
References: 
  • ندارد
 
  Persian Abstract Yearly Visit 87
 
Latest on Blog
Enter SID Blog